NCT02946788View on ClinicalTrials.gov

Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

March 13, 2017

Primary Completion Date

June 1, 2018

Study Completion Date

June 1, 2018

Conditions

Acne Vulgaris

Interventions

DRUG

Minocycline

BPX-01 1 or 2% topical gel will be applied to face once daily

Trial Locations (2)

33146

Study Center, Coral Gables

89128

Study Center, Las Vegas

Sponsors

Lead Sponsor

BioPharmX, Inc.

All Listed Sponsors

lead

BioPharmX, Inc.

INDUSTRY